Reference
Health Canada. Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms. Internet Document : 28 Jul 2020. Available from: URL: https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/73621a-eng.php
Rights and permissions
About this article
Cite this article
Health Canada approves first drug for treatment of COVID-19. Reactions Weekly 1817, 3 (2020). https://doi.org/10.1007/s40278-020-81962-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-81962-7